BioLife Solutions, Inc.
NASDAQ:BLFS
27.69 (USD) • At close January 8, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | BioLife Solutions, Inc. |
Symbool | BLFS |
Munteenheid | USD |
Prijs | 27.69 |
Beurswaarde | 1,284,461,568 |
Dividendpercentage | 0% |
52-weken bereik | 14.5 - 28.88 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Michael P. Rice |
Website | https://www.biolifesolutions.com |
An error occurred while fetching data.
Over BioLife Solutions, Inc.
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)